Cipla rises after getting EIR for Kurkumbh facility

10 Jun 2019 Evaluate

Cipla is currently trading at Rs. 554.95, up by 5.35 points or 0.97% from its previous closing of Rs. 549.60 on the BSE.

The scrip opened at Rs. 565.00 and has touched a high and low of Rs. 565.00 and Rs. 550.00 respectively. So far 69854 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 678.00 on 19-Sep-2018 and a 52 week low of Rs. 483.75 on 29-Jan-2019.

Last one week high and low of the scrip stood at Rs. 574.30 and Rs. 543.15 respectively. The current market cap of the company is Rs. 44912.06 crore.

The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 40.81% and 22.49% respectively.

Cipla has received the Establishment Inspection Report (EIR) for the inspection done by United States Food and Drug Administration (USFDA) at the Kurkumbh manufacturing facility. The inspection was conducted from March 11, 2019 to March 20, 2019.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1406.25 0.85 (0.06%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.